The Christie NHS Foundation Trust
Also known as: Anna Thomason | Brynn Chappell | Christie Hospital, Manchester | Christie Hospital, Manchester, UK | Christie Hospital NHS | Christie Hospital NHS Foundation Trust | Christie Hospital, UK | Christie NHS Foundation Trust | Department of Medical Oncology, Christie Hospital, Manchester, UK | Dpt. Clinical Oncology, The Christie, Manchester. | Fiona Thistlethwaite | Heather Driscoll | Prof Corinne Faivre-Finn | Professor Robert Hawkins | Sally Falk | The Christie Hospital | The Christie Hospital, Manchester | The Christie Hospital, Manchester, UK | The Christie Hospital, UK | The Christie National Health Service (NHS) Foundation Trust | The Christie NHS Foundation Trust | The Christie NHS Foundation Trust and the University of Manchester | The Christie NHS Foundation Trust - Christie Hospital | The Christie NHS Foundation Trust Clinical Trials Unit; UK | The Christie NHS Foundation Trust Manchester, UK | The Christie NHS Foundation Trust, Manchester, UK | The Christie NHS Foundation Trust, Manchester, United Kingdom | The Christie NHS Foundation Trust, The University of Manchester | The Christie NHS Foundation Trust, UK | The Christie research (Manchester)
Highest phase reached
Phase 3
First clinical trial
Apr 1, 1992Last known activity
Dec 1, 2025
Timeline
1880s
- Jun 1, 1887
The Christie NHS Foundation Trust— Founded
Drugs by trial phase (113 distinct, 89 trials)
Phase 3 (45 own, 0 via acquisition)
Phase 2 (48 own, 0 via acquisition)
Phase 1 (14 own, 0 via acquisition)
Other trials (6 own, 0 via acquisition)
Indications
Studied for
- Aspergillosis
- Biliary Tract Neoplasms
- Breast Neoplasms
- Carcinoid Heart Disease
- Carcinoid Tumor
- Carcinoma
- Carcinoma, Merkel Cell
- Carcinoma, Neuroendocrine
- Carcinoma, Non-Small-Cell Lung
- Carcinoma, Ovarian Epithelial
- Carcinoma, Renal Cell
- Carcinoma, Squamous Cell
- Carcinosarcoma
- Central Nervous System Neoplasms
- Cholangiocarcinoma
- Colorectal Neoplasms
- Endometrial Neoplasms
- Ependymoma
- Esophageal Neoplasms
- Gallbladder Neoplasms
- Glioblastoma
- Head and Neck Neoplasms
- Heart Diseases
- Kidney Neoplasms
- Leukemia
- Leukemia, Lymphocytic, Chronic, B-Cell
- Leukemia, Lymphoid
- Leukemia, Myeloid
- Leukemia, Myeloid, Acute
- Lung Neoplasms
- Lymphoma
- Lymphoma, B-Cell
- Lymphoma, Follicular
- Lymphoma, Large B-Cell, Diffuse
- Lymphoma, Non-Hodgkin
- Lymphoma, T-Cell
- Lymphoma, T-Cell, Cutaneous
- Malignant Carcinoid Syndrome
- Melanoma
- Mesothelioma
- Mixed Tumor, Mullerian
- Myelodysplastic Syndromes
- Nelson Syndrome
- Neoplasm Metastasis
- Neoplasms
- Neoplasms, Unknown Primary
- Nervous System Neoplasms
- Neuroectodermal Tumors
- Neuroectodermal Tumors, Primitive
- Neuroendocrine Tumors
- Ovarian Neoplasms
- Pancreatic Neoplasms
- Precursor Cell Lymphoblastic Leukemia-Lymphoma
- Preleukemia
- Prostatic Neoplasms
- Rectal Neoplasms
- Recurrence
- Sarcoma
- Sarcoma, Kaposi
- Serotonin Syndrome
- Squamous Cell Carcinoma of Head and Neck
- Stomach Neoplasms
- Syndrome
- Triple Negative Breast Neoplasms
Recent trials (50)
- NCT07268339Lead sponsorPhase 3Dec 1, 2025
- NCT06988475OfficialPhase 2/Phase 3Nov 19, 2024
- NCT06434493Lead sponsorN/ANov 1, 2024
- NCT06380816OfficialPhase 1/Phase 2Jul 9, 2024
- NCT05770544Overall official - principal investigatorPhase 2/Phase 3Dec 31, 2023
- NCT05770102Overall official - principal investigatorPhase 2/Phase 3Nov 30, 2023
- NCT05770037Overall official - principal investigatorPhase 2/Phase 3Oct 31, 2023
- NCT05786716Overall official - principal investigatorPhase 2/Phase 3Mar 7, 2023
- NCT05768178Overall official - principal investigatorPhase 2/Phase 3Mar 1, 2023
- NCT05722886Overall official - principal investigatorPhase 2/Phase 3Mar 1, 2023
- NCT05666349Overall official - principal investigatorPhase 1Jan 1, 2023
- NCT04901988Lead sponsorPhase 2/Phase 3Nov 8, 2021
- NCT04901988Overall official - principal investigatorPhase 2/Phase 3Nov 8, 2021
- NCT04389229Overall official - principal investigatorPhase 1/Phase 2Jul 1, 2020
- NCT04128072Overall official - principal investigatorPhase 2May 31, 2020
Details
- Founded
- Manchester, GB Jun 1, 1887
- Last known activity
- Dec 1, 2025
Notes
--- Pre-folding founded info: 2007-04-01 Withington GB https://en.wikipedia.org/wiki/The_Christie_NHS_Foundation_Trust ---